The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Chandra Bhagat Pharma Ltd

Chandra Bhagat Pharma Ltd

BSE 542934 · NSE CBPL · ISIN INE07QQ01016 · Group M · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹50.40

+1.00%

BSE close, 28 August 2026

Market cap

₹38.03 cr

0.8 cr shares · Micro cap

Free float

₹10.57 cr

as published

P/E · P/B

13.4× · —

EPS ₹3.75 · BV —

FY25-26 rev / PAT

116.27 / 3.05

₹ cr, as filed

Filings, window

10

2 selected · 20%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹29.70 52-WK HIGH ₹55.00 ₹50.40 82% of range
Against 52-week high-8.4%
Against 52-week low+69.7%
Day change+1.00%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹3.75
Price / earnings13.44×
Price / book—
Book value — derived, price ÷ P/B—
Return on equity—
Operating margin—
Net margin—

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Mar-26 · Q 90.73 2.60 3.44 5.73% 2.86%
Sep-25 · Q 25.55 0.23 0.30 6.71% 0.90%
FY25-26 116.27 3.05 4.04 6.20% 2.62%

Quarter on quarter

Revenue, quarter on quarter
+255.1%
Net profit, quarter on quarter
+1,030.4%
Operating margin, quarter on quarter
-98 bps

Disclosure profile 10 filings in the window

0 median 17.0 p75 · 25 sector max 52 10 16th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Change in Management1
Selected sub-total2
Procedural
AGM / EGM3
General2
Annual Report1
Board Meeting1
Trading Window1
Procedural sub-total8
Total10

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group M, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

10 filings · 2 selected · busiest 2026-08-06

Filing rhythm · the twelve most recent

2026-07-212026-10-01

SelectedProcedural

Filings

10 in the window

  1. 1 October 2026 ·

    Trading Window

    Closure of Trading Window

    Notice of Closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  2. 30 September 2026 ·

    Change in Management

    Change in Management

    Disclosure under regulation 30 for resignation of Company Secretary & Compliance Officer.

    Company Update / Change in Management View filing →

  3. 3 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Declaration of Voting Result along with Scrutinizer Report of Annual General Meeting of the company.

    AGM/EGM / AGM View filing →

  4. 1 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Gist of the Proceeding of the 23rd Annual General Meeting ('AGM') of the Company held on Tuesday, September 01, 2026.

    AGM/EGM / AGM View filing →

  5. 20 August 2026 ·

    General

    Corrigendum Of AGM Notice

    Please find attached the corrigendum of AGM notice.

    Company Update / General View filing →

  6. 6 August 2026 ·

    AGM / EGM

    Notice Of Shareholders Meeting Scheduled On 1St September, 2026

    Please find attached the notice of shareholders meeting scheduled on 1st September, 2026.

    AGM/EGM / AGM View filing →

  7. 6 August 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Annual Report 2025-26

    Others / Reg. 34 (1) Annual Report View filing →

  8. 5 August 2026 ·

    Board Outcome

    Board Meeting Outcome for For Approval Of Preferential Issue And Other Agenda

    Please find attached outcome of Board Meeting.

    Board Meeting / Outcome of Board Meeting View filing →

  9. 30 July 2026 ·

    Board Meeting

    Board Meeting Intimation for Fund Raising Through Preferential Issue.

    Chandra Bhagat Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 ,inter alia, to consider and approve Fund raising through ....

    Board Meeting / Board Meeting View filing →

  10. 21 July 2026 ·

    General

    Non-Applicability Of CG Report

    Non-applicability of Corporate Governance Report

    Company Update / General View filing →

RSS feed for Chandra Bhagat Pharma Ltd · the 50 most recent filings